| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA266: Mannitol dry powder for inhalation for treating cystic fibrosis |
|
Medicine details |
|
| Medicine name | mannitol (Bronchitol®) |
| Formulation | 40 mg inhalation powder |
| Reference number | 1230 |
| Indication | Treatment of cystic fibrosis in adults aged 18 years and above as an add-on therapy to best standard of care |
| Company | Pharmaxis Pharmaceuticals Ltd |
| BNF chapter | Respiratory system |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 10/02/2012 |
| NICE guidance | TA266: Mannitol dry powder for inhalation for treating cystic fibrosis |